(301520.SZ) intends to acquire a 75.52% stake in Faidherbe to further improve the layout of its innovative drug sector business.

The Zhitong financial and economic APP news, Wanhua Medicine (301520.SZ) announced that the company plans to acquire 75.52% equity of Anhui Sidesheng Pharmaceutical Technology Co., Ltd. ("Sidesheng") with its own funds or self-raised funds totaling 302 million yuan. After the transaction is completed, Sidesheng will become a subsidiary controlled by the company.